{"created":"2023-05-15T14:43:00.102911+00:00","id":58917,"links":{},"metadata":{"_buckets":{"deposit":"8f52e1a4-fbe6-448c-ab3d-8c2c9b0409af"},"_deposit":{"created_by":1,"id":"58917","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"58917"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00058917","sets":["11"]},"author_link":["586982","586984","586983","586980","586978","586977","586981","586985","586979","586976"],"item_10004_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-11","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"48","bibliographicPageStart":"46","bibliographic_titles":[{"bibliographic_title":"月刊インナービジョン"}]}]},"item_10004_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"著者らは量子科学技術研究開発機構において、放射性ハロゲンを利用したがんの診断薬及び治療薬の開発に取り組んでおり、α線を放出する211Atを用いた薬剤開発に成功した。本項では、世界におけるα線放出核種を用いたがん治療薬剤の開発状況を述べるとともに、211 At製造とその標識法の開発の現状、211 At標識薬剤開発の国内最新動向、α薬剤における線量評価、211 At イメージングの意義について解説した。","subitem_description_type":"Abstract"}]},"item_10004_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"インナービジョン"}]},"item_10004_relation_10":{"attribute_name":"ISBN","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"4902131641","subitem_relation_type_select":"ISBN"}}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"石岡, 典子"}],"nameIdentifiers":[{"nameIdentifier":"586976","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"渡辺, 茂樹"}],"nameIdentifiers":[{"nameIdentifier":"586977","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"大島, 康宏"}],"nameIdentifiers":[{"nameIdentifier":"586978","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"坂下, 哲哉"}],"nameIdentifiers":[{"nameIdentifier":"586979","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"河地, 有木"}],"nameIdentifiers":[{"nameIdentifier":"586980","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石岡 典子","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586981","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"渡辺 茂樹","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586982","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"大島 康宏","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586983","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"坂下 哲哉","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586984","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"河地 有木","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586985","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"日本発α線放出核種を用いた がん治療薬剤の開発 ─製造からイメージングまで","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"日本発α線放出核種を用いた がん治療薬剤の開発 ─製造からイメージングまで"}]},"item_type_id":"10004","owner":"1","path":["11"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-12-14"},"publish_date":"2018-12-14","publish_status":"0","recid":"58917","relation_version_is_last":true,"title":["日本発α線放出核種を用いた がん治療薬剤の開発 ─製造からイメージングまで"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T22:10:46.441414+00:00"}